Investigational Drug Information for Nalfurafine
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
What is the drug development status for Nalfurafine?
Nalfurafine is an investigational drug.
There have been 7 clinical trials for Nalfurafine.
The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2008.
The most common disease conditions in clinical trials are Pruritus, Kidney Failure, Chronic, and Kidney Diseases. The leading clinical trial sponsors are Toray Industries, Inc, SK Chemicals Co.,Ltd., and SK Chemicals Co., Ltd.
Summary for Nalfurafine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 298 |
| WIPO Patent Applications | 151 |
| Japanese Patent Applications | 89 |
| Clinical Trial Progress | Phase 3 (2008-04-01) |
| Vendors | 18 |
Recent Clinical Trials for Nalfurafine
| Title | Sponsor | Phase |
|---|---|---|
| A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet | Shenyang Sunshine Pharmaceutical Co., LTD. | Phase 3 |
| TRK-820 Study in Subjects on Hemodialysis With or Without Uremic Pruritus | Toray Industries, Inc | Phase 1 |
| Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis | Toray Industries, Inc | Phase 2 |
Clinical Trial Summary for Nalfurafine
Top disease conditions for Nalfurafine
Top clinical trial sponsors for Nalfurafine
US Patents for Nalfurafine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
